We help customers assess the risk of anaphylactogenic potential of purified donor plasma products such as intravenous immunoglobulins.

This enables them to identify individuals within their donor pool, whose plasma triggers hypersensitivity reactions in recipients, and take appropriate action to ensure the integrity of the batches they place on the market.

Inversely, we are also able to test individual donors, or pools thereof, for the potential of their plasma to trigger hypersensitivity reactions in recipients using our customizable mast cell assay, thereby ensuring that reactive donor plasma are excluded from future products.

Benefits:

• Promote recipient safety: Ensure that batches are not contaminated before distribution

• Early detection: Identify problematic donors before their plasma enters the product pool and reduce the risk of product recalls.